Bio-Techne Corp (TECH)

NASDAQ
84.99
+3.22(+3.94%)
After Hours
84.99
0.00(0.00%)
- Real-time Data
  • Volume:
    1,962,813
  • Day's Range:
    81.18 - 85.39
  • 52 wk Range:
    68.00 - 130.74
Trading near 52-week Low

Bio-Techne has hit the lowest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

TECH Overview

Prev. Close
81.77
Day's Range
81.18-85.39
Revenue
1.12B
Open
81.74
52 wk Range
68-130.74
EPS
1.86
Volume
1,962,813
Market Cap
3.34B
Dividend (Yield)
1.28
(0.38%)
Average Vol. (3m)
1,259,267
P/E Ratio
-
Beta
1.25
1-Year Change
-27.98%
Shares Outstanding
39,242,384
Next Earnings Date
Feb 07, 2023
What is your sentiment on Bio-Techne?
or
Market is currently closed. Voting is open during market hours.

Bio-Techne Corp News

Bio-Techne Corp Analysis

Bio-Techne Corp Company Profile

Bio-Techne Corp Company Profile

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.

Read More

Analyst Price Target

Average105.08 (+23.64% Upside)
High125
Low81.25
Price84.99
No. of Analysts13
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellSellStrong BuyBuy
Technical IndicatorsStrong BuyStrong BuySellStrong BuyStrong Sell
SummaryStrong BuyNeutralSellStrong BuyNeutral
  • OMG, P/E =82 .
    0
    • AIRI and TECH are good stocks
      1
      • AIRI? Seriously?
        0
    • Products like AR glasses and AR helmets will become more and more in the next three years.
      0
      • come to rtalb🇹🇷
        2